Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?

Jakob Wested; Timo Minssen; Esther  Van Zimmeren

Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?

Jakob Wested, Timo Minssen, Esther Van Zimmeren

Abstract

The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.

Original language	English
Publication date	Jul 2018
Publisher	Harvard Law School's Bill of Health blog
Publication status	Published - Jul 2018

Access to Document

http://blogs.harvard.edu/billofhealth/2018/07/14/will-the-epos-enlarged-board-of-appeal-step-into-the-crispr-patent-battle-and-reconsider-the-all-applicants-approach/

Cite this

Wested, J., Minssen, T., & Van Zimmeren, E. (2018, Jul). Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach? Harvard Law School's Bill of Health blog. http://blogs.harvard.edu/billofhealth/2018/07/14/will-the-epos-enlarged-board-of-appeal-step-into-the-crispr-patent-battle-and-reconsider-the-all-applicants-approach/

Wested, J , Minssen, T & Van Zimmeren, E 2018, Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?. Harvard Law School's Bill of Health blog. <http://blogs.harvard.edu/billofhealth/2018/07/14/will-the-epos-enlarged-board-of-appeal-step-into-the-crispr-patent-battle-and-reconsider-the-all-applicants-approach/>

@misc{b8ac9679f4cc4727b90b0f3a3c63c2e6,

title = "Might the EPO{\textquoteright}s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?",

abstract = "The Broad Institute is facing a formidable task in defending the revoked CRISPR patent claims in their pending appeal at the EPO. Ultimately, some of the issues might still be referred to the Enlarged Board of Appeal. However, this might require a significant amount of legal and rhetorical agility.",

author = "Jakob Wested and Timo Minssen and {Van Zimmeren}, Esther",

year = "2018",

month = jul,

language = "English",